Using BupPractice and Getting Credit
If you start the activity and are not satisfied for any reason, we will refund your training fee within 60 days of the original payment. Refunds will be in the original form of payment. After 60 days we are unable to offer a refund. If you complete the activity, we will not issue a refund. Email email@example.com with requests or questions.
If you complete the survey, we will provide a $25 donation to support a local organization in NC related to addiction or may be eligible for a $25 refund on the cost of your training. To be eligible you must have paid for the training yourself within the past 50 days. Not applicable to coupon users.
Please send an email to firstname.lastname@example.org and we will be happy to create an invoice for your purchasing department, so you can be reimbursed, etc. Our EIN is 51-0344326.
Physician Long version: This website offers an official training activity that satisfies the Substance Abuse and Mental Health Services Administration’s (SAMHSA) training requirement for a DATA-2000 waiver. This means that you can take the 10-module activity on BupPractice.com to qualify for your waiver to prescribe buprenorphine. This training activity is provided by the American Society of Addiction Medicine (ASAM). The website is an ASAM online buprenorphine training activity that is presented in collaboration with Clinical Tools, Inc. ASAM also holds live buprenorphine trainings across the United States. Learn more about ASAM at their website.
NP/PA Short version: Your 24 hour training activity involves the 10 modules on Buppractice.com (part 1) and 14 modules on two other websites (parts 2a and 2b), which you will be able to reach from the bottom of the activity page on this website, Buppractice.com. Once you complete all modules and have requested continuing education credit for Part 1 (8 hours) and Part 2 (16 hours), you can apply for your waiver to prescribe buprenorphine online.
NP/PA Long version: This website offers 8-9 hours of an official training activity that satisfies the Substance Abuse and Mental Health Services Administration’s (SAMHSA) training requirement for a DATA-2000 waiver. A later law, CARA 2016 allows NPPAs to become waivered if they complete a total of 24 hours. The additional 16 hours of training are available across two other websites, which you will be able to reach from the bottom of the activity page on this website, Buppractice.com. This means that you can take the 10-module activity on BupPractice.com, plus 14 additional modules on two other websites, in order to qualify for your waiver to prescribe buprenorphine. This training activity is provided by the American Society of Addiction Medicine (ASAM). These training activities are an ASAM online buprenorphine training activity for NPs and PAs that is presented in collaboration with Clinical Tools, Inc. ASAM also holds live buprenorphine trainings across the United States. Learn more about ASAM at their website.
Physicians and Physician Assistants: You can receive up to 9 hours of AMA PRA Category 1 Credit (TM) for completing the 10-course training activity on our website.
Nurse Practitioners: You can receive up to 9 hours of District of Columbia Board of Nursing (DCBN) credit for the modules on this website, 24 hours for the entire training.
Physician assistants. You can receive up to 9 hours of Florida Academy of Physician Assistants (FAPA) credit for the modules on this website, 24 hours for the entire training.
A letter of completion for up to 9 hour(s) is available for modules on this website those not getting the above types of credits.
These are the only credit types being offered at this time.
The CARA 2016 law provides that nurse practitioners and physician assistants who can prescribe narcotics are able to prescribe buprenorphine, in addition to the MDs and DOs who have been able to prescribe it since 2000. A 24 hour training is required. The full 24 hour training is available through this online activity.
Other clinicians are welcome to take the Buppractice training activity for educational purposes.
Getting Your Waiver to Prescribe Buprenorphine
You should apply for the waiver if you want to prescribe buprenorphine. After you complete the 10-course training activity (24 courses for NPs/PAs) you will be qualified to apply for the waiver. Visit SAMHSA Buprenorphine Waiver Management to see the other ways that physicians can become qualified to prescribe buprenorphine.
For the waiver form, ASAM (American Society of Addiction Medicine) is the official provider of this online training activity. The activity was developed by Clinical Tools, Inc. On the waiver form, you will see a question listed under the title “8. CERTIFICATION OF QUALIFYING CRITERIA”. Please select the checkbox titled “American Society of Addiction Medicine”.
The documentation the question is referring to is the DATA 2000 Training Certificate. SAMHSA now requires that you send a copy of your training certificate via email to email@example.com OR via fax to 301-576-5237. We also send the names of all people completing the training within around one week of completion as confirmation.
You must send your training certificates electronically, via email to firstname.lastname@example.org OR via fax to 301-576-5237. Clinical Tools also sends confirmation of your completion to SAMHSA.
After you complete the buprenorphine training activity and required activity post-training assessments, you will be qualified to apply for the waiver. Providers must submit a waiver form to CSAT if they plan on prescribing buprenorphine. Providers should at least wait 45 days to begin prescribing. If caught by the DEA prescribing without being certified, there could be consequences. Further, pharmacies contact CSAT/SAMHSA to verify if a provider is certified; they will not fill the prescription to non-certified providers. Note that providers who have completed buprenorphine training can immediately treat one patient emergently but must wait until getting their prescribing identification number before taking a caseload of patients.
According to the SAMHSA website, “A place to check “Immediate” is included on the form to address a provision in the Drug Addiction Treatment Act to permit treatment while a notification is under review. Checking “Immediate” is only one of three requirements that a provider must meet in order to start a patient on treatment, and treatment is limited to ONE patient per form submitted. (Each form must have a different submission date.)The three requirements are that, first, the provider must “in good faith” meet the criteria for obtaining a waiver (i.e., valid medical license, valid DEA registration, credentialing, or 8 hours of qualifying training). Second, the provider must check “Immediate” on the waiver. Third, the provider must contact the Buprenorphine Information Center at 1-866-BUP-CSAT to verify that the notification form has been received and to notify CSAT of his/her intent to begin treating ONE patient. Since the provider will not have the unique identifying number, pharmacists may question prescriptions received under this provision. Pharmacists may contact the Buprenorphine Information Center if additional information is needed.”
You can check with CSAT/SAMHSA at their hotline 1-866-BUP-CSAT (1-866-287-2728) to check on the status. Allow 45 days for CSAT to review your Buprenrophine Waiver Notification form.
NEITHER ASAM nor us (Clinical Tools) is involved in the CSAT or DEA review process.
No, your DEA number and X number do not change when you move from state to state. However, some states have an additional CDS (controlled dangerous substance) number, which may change. If you move be sure to update your practice address with the DEA.
The waiver application that must be submitted for licensing is provided by SAMHSA. For any issues or questions regarding the waiver application, please contact SAMHSA at email@example.com.
Once you complete the “Buprenorphine Training: Waiver Training for NPs & PAs [Part 1: 8 of 24 hours]” or “SBIRT and Motivational Interviewing: Waiver Training for NPs & PAs [Part 2a: 5 of 24 hours]” and “Opioids, Pain, and Risk Reduction: Waiver Training for NPs & PAs [Part 2b: 11 of 24 hours]”, your completion information is recorded in our records. If you have an NP or PA degree, your information is sent to SAMHSA at the beginning of the next work week.
Things to Note:
- You will need to electronically send a copy of your training certificates with your waiver application via email to firstname.lastname@example.org OR via fax to 301-576-5237.
- You must have an NP or PA degree listed under your account in order for us to send off your information.
- If you plan on applying for a waiver, you must select the full amount of credit for each section, which is 8 hours for BupPractice and 16 hours for SBIRT(5 hrs) AND OpioidRisk(11 hrs).
The online Notification Form for NPPAs became available 2/27/17 and is the same one completed by MDs/DOs: the online Buprenorphine Waiver Notification form. Once you have completed all parts of the waiver training activity, you must fill out the online form on SAMHSA/CSAT’s website. In addition to submitting the application, providers must also send copies of your certificates to SAMHSA via email at email@example.com or by faxing to 301-576-5237. For NPs and PAs this is one 8 hour certificate and one 16 hour certificate. For more information, you may visit SAMHSA’s site Qualify for Nurse Practitioners (NPs) and Physician Assistants (PAs) Waiver.
About the Website
This site was developed to train both providers who qualify to prescribe buprenorphine and other clinicians who treat opioid-dependent patients with buprenorphine or manage and refer patients with opioid use disorder. Initially, only MDs and DOs could become waivered to prescribe buprenorphine and have training, however, the CARA 2016 law provides that nurse practitioners and physician assistants are able to prescribe it as well. They are required to take 24 hours of training instead of the 8 hours required for physicians.
Buprenorphine Practice was developed by Clinical Tools, Inc., funded by a contract with the National Institute on Drug Abuse (#HHSN271200555303C). Clinical Tools, Inc., is a small, physician-run business dedicated to harnessing the potential of the Internet to create scalable, usable, and broadly available tools for health researchers, clinicians, and consumers.
Clinical Tools, Inc. will not share your personal information with any third parties. However, we will provide ASAM with a list of all qualified learners who have completed the training activity.
Need More Information?
Please contact us to request additional help.